Baoan Chen

2.1k citations
82 papers · 1.6k indexed · 1 hit paper · h-index 22

Baoan Chen

79 papers receiving 1.6k citations

Hit Papers

Non-small cell lung cancer (NSCLC): A review of risk fact...155202320262024202550100150

Peers

Baoan Chen
Comparison fields: 5 of 118
  • Oncology 586
  • Hematology 185
  • Cancer Research 172
  • Biomaterials 138
  • Molecular Biology 644
Replace Hojjatollah Nozad Charoudeh with:
Hojjatollah Nozad Charoudeh Iran
Peipei Xu China
Tao Fang China
Enrico Conte Italy
Xiaozhong Wang China
Donato Colangelo Italy
Jing Jin China
Dongqin Yang China
Sheela A. Abraham Canada
Anna Laurenzana Italy
Baoan Chen relative to Hojjatollah Nozad Charoudeh Iran Hojjatollah Nozad Charoudeh's profile →
Citations per field
00.5×3.1×
Hojjatollah Nozad Charoudeh · 1×
Citations per year

Countries citing papers authored by Baoan Chen

Since Specialization
Citations

This map shows the geographic impact of Baoan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoan Chen more than expected).

Fields of papers citing papers by Baoan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoan Chen. The network helps show where Baoan Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Baoan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Baoan Chen Line = papers co-authored together Baoan Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202319
2 202115
3 20215
4 202026
5 201815
6 201720
7 2017200
8 201721
9 201621
10 201555
11 201528
12 201517
13 20145
14
Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
20123
15 201210
16 201216
17 201138
18 201114
19 201012
20 200934

About Baoan Chen

Baoan Chen is a scholar working on Oncology, Genetics and Hematology, having authored 82 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Lymphoma Diagnosis and Treatment (10 papers), Cancer therapeutics and mechanisms (9 papers), Nanoparticle-Based Drug Delivery (8 papers), CAR-T cell therapy research (8 papers), Lung Cancer Treatments and Mutations (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Oncology (586 citations), Hematology (185 citations) and Cancer Research (172 citations). Baoan Chen has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Haijun Zhang, Liting Guo, Runzhe Chen, Jing Chen, Fan Fan, Xuemei Wang, Hui Jiang, Jifeng Feng, Xinchen Sun and Lü Cheng. Their work appears in journals such as Nature Communications, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026